Senior Research Associate / Scientist – Immunology and Inflammation at Genesis Therapeutics

San Diego, California, United States

Genesis Therapeutics Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • MSc or PhD degree in immunology, molecular and cell biology, or a related field, with 5+ years (MSc) or 3+ years (PhD) of relevant industry experience
  • Meticulous and detail-oriented approach to experimental design, with full commitment to scientific rigor and creative solutions
  • Solid understanding of autoimmune and inflammatory mechanisms combined with a passion for pre-clinical drug research as evidenced by previous work experience
  • Proven experience with high-quality, immune-relevant assays for compound profiling and MOA evaluations, including activation/proliferation assays, cell differentiation, co-culture experiments, cytokine analysis, immune phenotyping, ex vivo culture, and functional profiling of blood
  • Fluency with MSD, Luminex, or other multiplex assays for bio-analyte quantification
  • Robust experience with multi-color flow cytometry
  • Experience in live cell imaging, IF staining, high-content/high-throughput imaging, and quantitative image analysis (preferred)
  • Critical understanding of assay development and validation for screening and compound progression purposes
  • Highly organized workstyle with excellent written and oral communication skills
  • Practical know-how with industry standard equipment like automated plate readers, liquid handlers, and robotic platforms (highly valued)
  • Proficiency with data visualization and statistical analysis using contemporary software tools

Responsibilities

  • Autonomously plan, design, and execute cell- and patient sample-based experiments to support the I&I pipeline
  • Maintain a hands-on approach while contributing intellectually to experimental and project needs
  • Analyze, interpret, and integrate complex datasets across multiple assay types
  • Document data meticulously using ELN and state-of-the-art analysis tools
  • Stay at the forefront of latest research through literature review and critical evaluation of available data sources
  • Ensure team progress and success through efficient communication with key personnel across the organization

Skills

Immunology
Assay Development
Cell Biology
Biochemistry
In Vitro Assays
ELN
Data Analysis
Autoimmune Diseases

Genesis Therapeutics

AI-driven drug discovery for pharmaceuticals

About Genesis Therapeutics

Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.

Burlingame, CaliforniaHeadquarters
2019Year Founded
$272.5MTotal Funding
SERIES_BCompany Stage
AI & Machine Learning, BiotechnologyIndustries
51-200Employees

Benefits

Competitive salary
Equity
Medical, dental, & vision insurance
401(k) program

Risks

Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.
Over-reliance on partnerships could lead to financial instability if drugs aren't successful.
Rapid AI advancements may render current models like GEMS obsolete without updates.

Differentiation

Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.
The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.
Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Upsides

Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.
$224 million equity investment boosts research and development capabilities.
Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

Land your dream remote job 3x faster with AI